|
|
Phlebology
Omega Laboratories Limited offers a complete range of potentially exclusive sclerosing products.
Since its introduction in the 50s, SCLEROTHERAPY has improved continuously thanks to constant technical improvements and knowledge sharing. In Canada, Omega Laboratories Limited has been offering a complete line of sclerosing products made in accordance with the most advanced technological standards for over 25 years. We are involved in the training process through our various presentations to the Canadian Society of Phlebology of which we are a corporate member.
|
|
|
|
Sclerodex ®
|
|
| |
|
 |
5 vials of 10 mL
Dextrose USP 250 mg/mL
Sodium Chloride USP 100 mg/mL
INDICATIONS
SCLERODEX® is a relatively weak sclerosant recommended for the local treatment of varicose veins, especially small vessels and communicating veins of the superficial venous system. It is also used as an adjunct to the surgical treatment of varicose veins of the lower limbs. Sclerodex is a mild sclerosing solution.
DOSAGE
Depends on the length and size of the vein to be sclerosed. Do not inject more than 10 mL per visit, at the rate of 0.1 to 1 mL maximum per injection site; keep a 5 cm space between injection sites.
See prescribing information. |
| |
|
|
Sclerodine ® 6
|
|
| |
|
 |
Iodine 600 mg/10 mL
(60 mg/mL)
Sodium Iodine 900 mg/10 mL
(90 mg/mL)
INDICATIONS
A sclerosing agent of varicose veins. Since iodine is a strong sclerosing agent, it may be used for sclerosis of truncal veins of lower legs, i.e. internal saphena and collaterals, external saphena, and in some cases, large communicating veins. A venous insufficiency of a truncal vein must be treated prior to treating its related small superficial vessels. SCLÉRODINE® 6 is a strong sclerosing solution.
DOSAGE
SCLÉRODINE® 6 is administered by injection into the lumen of the varicose vein which is to be sclerosed. Dosage range is variable and depends entirely on the size and length of the vein to be injected; it also depends on the patient's susceptibility to the sclerosing agent. However, as a guideline, the following are the maximum quantities that can be injected during 1 visit according to the solution concentration Sclerodine 6%: 3 mL. Sclerodine is administered in divided doses with a 5 cm space between each injection site.
See prescribing information.
|
| |
|
Tromboject ®
|
|
| |
|
 |
Tetradecyl Sulfate Omg. Std
10 mg/mL 10 vials of 2 mL
30 mg/mL 10 vials of 2 mL
30 mg/mL 5 vials of 5 mL
INDICATIONS
TROMBOJECT® is a sclerosing solution for intravenous treatment of varicose veins. Tromboject is primarily used in the treatment of varicose veins of the legs by compression sclerotherapy. The action of Sodium Tetradecyl Sulfate is one of direct irritation of the intima of the vein wall. Compression promotes the occlusion of the vein by fibrosis. Tromboject is a strong sclerosing solution.
DOSAGE
The concentration and dosage range are variable and depend on the size of the veins to be treated.
Usual adult dose for occlusion:
Small veins:
0.5-2 mL of the 10 mg/mL injection
For medium or large veins:
0.5-2 mL of 30 mg/mL is used
The volume of the injection should be kept small and the drug should be injected slowly. No more than 2 mL of either solution should be injected in a single varicosity and no more than 10 mL of the 30 mg/mL injection should be used for one treatment. The interval between treatments is usually 5-7 days.
See prescribing information.
|
| |
|
|
Saliject ®
|
|
| |
|
|
|
Sodium Salicylate Omg. Std
5.7 g/10 mL (570 mg/mL)
INDICATIONS
SALIJECT® is used for the local treatment of medium and small varicose veins. It is a sclerosing solution of medium strength.
DOSAGE
Dilute with lidocaine 1% without epinephrine, to yield a solution concentration of approximately 30%. Administered by i.v. injection. The maximum quantity that can be administered into 1 injection site is 2 mL; the maximum total quantity that can be injected is 8 to 10 mL. 5 to 8 cm should separate each injection site.
See prescribing information.
|
|
